David Mountcastle - 06 Sep 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas Bartrum, as attorney-in fact
Issuer symbol
PRVA
Transactions as of
06 Sep 2022
Transactions value $
-$221,498
Form type
4
Filing time
08 Sep 2022, 16:06:34 UTC
Previous filing
08 Aug 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, par value $0.01 per share Options Exercise $25.7K +12.9K +8.43% $2.00* 165K 06 Sep 2022 Direct
transaction PRVA Common Stock, par value $0.01 per share Sale -$247K -6.16K -3.72% $40.14 159K 06 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -12.9K -20.13% $0.00 51K 06 Sep 2022 Common Stock 12.9K $2.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transaction reported in this Form 4, 38,380 of the stock options are fully vested and exercisable. 25,519 will vest on October 29, 2022.